KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $0.315 $0.440 Friday, 26th Apr 2024 GLMD stock ended at $0.392. This is 0.229% less than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 5.87% from a day low at $0.373 to a day high of $0.395.
90 days $0.300 $0.466
52 weeks $0.260 $5.63

Historical Galmed Pharmaceuticals Ltd. prices

Date Open High Low Close Volume
Mar 07, 2016 $5.31 $5.45 $4.95 $5.18 11 600
Mar 04, 2016 $5.27 $5.30 $5.12 $5.12 8 400
Mar 03, 2016 $5.43 $5.43 $4.85 $4.97 13 000
Mar 02, 2016 $5.13 $5.30 $4.65 $4.95 17 500
Mar 01, 2016 $4.71 $4.96 $4.50 $4.61 12 100
Feb 29, 2016 $5.07 $5.43 $4.61 $4.61 15 200
Feb 26, 2016 $4.24 $5.40 $4.24 $5.13 22 000
Feb 25, 2016 $4.49 $4.51 $4.42 $4.45 17 200
Feb 24, 2016 $5.15 $5.15 $4.32 $4.45 37 700
Feb 23, 2016 $4.89 $5.00 $4.66 $4.86 24 600
Feb 22, 2016 $5.21 $5.21 $4.93 $4.95 13 400
Feb 19, 2016 $4.98 $5.51 $4.78 $5.17 4 400
Feb 18, 2016 $5.64 $5.72 $5.38 $5.38 8 700
Feb 17, 2016 $5.20 $5.30 $5.04 $5.05 3 700
Feb 16, 2016 $4.86 $5.25 $4.86 $5.06 9 900
Feb 12, 2016 $4.74 $5.69 $4.74 $4.78 47 000
Feb 11, 2016 $4.90 $5.72 $4.50 $4.79 24 000
Feb 10, 2016 $5.06 $5.35 $4.98 $5.03 12 700
Feb 09, 2016 $5.30 $5.30 $5.07 $5.10 17 300
Feb 08, 2016 $6.03 $6.03 $5.41 $5.50 9 900
Feb 05, 2016 $6.37 $6.47 $6.00 $6.08 12 400
Feb 04, 2016 $5.90 $6.46 $5.81 $6.42 11 200
Feb 03, 2016 $6.24 $6.24 $5.75 $5.94 61 300
Feb 02, 2016 $6.10 $7.00 $6.10 $6.21 8 000
Feb 01, 2016 $6.89 $6.89 $6.01 $6.06 7 300
Click to get the best stock tips daily for free!

About Galmed Pharmaceuticals Ltd.

Galmed Pharmaceuticals Ltd. Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or type-II-diabetes mellitus. The company also evaluates Aramchol through ARRIVE Study, a Phase IIa clinica... GLMD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT